This web-based opioid prevention toolkit from Oregon Health Authority’s Heal Safely campaign is intended to be used by community health workers and public health officials to help communities find safe non-opioid options for healing safely and addressing pain. Continue reading
Resource Tag: Pain Management
Alternative treatments for pain
Acupuncture
Chiropractic
Massage
Yoga
Rolfing
COVID-19 Resources
The National Academies of Medicine’s COVID-19 response page includes resources for supporting individuals with substance use disorder and those who experience pain. It includes links to NAM’s publications and webinars as well as links to other organizations producing materials to address the needs of these individuals. Continue reading
COVID-19
UPDATED March 11, 2021:
The COVID-19 public health emergency is particularly challenging for people in treatment for substance use disorder, people in recovery, and people who use drugs. This collection features educational resources that can be adapted for local settings, specific guidance on harm reduction, recovery housing and providing peer support services during the pandemic, and links to websites that provide high-quality information, data, and/or examples for local communities to adopt. Continue reading
Intersection of Pain and Addiction
This 6 minute video titled “Intersection of Pain and Addiction” from a clinician at Boston Medical Center’s Grayken Center for Addiction describes how addiction often develops after treatment for pain, how individuals with substance use disorder experience pain differently, and how important it is to treat pain in individuals with current SUD or a history of SUD. Continue reading
Nebraska Pain Management Guidance Document: A Provider and Community Resource
The 2017 Nebraska Pain Management Guidance document was developed by an expert advisory task force consisting of actively practicing clinicians and prescribers, public health officers and senior state officials. The guidance is notable for addressing a broad range of topics including Continue reading
Tips for Talking about Opioids and Pain with Patients
Health care providers often request guidance on how to have conversations with patients about opioids, pain treatment, addiction and other topics that may be challenging. In this collection, we have gathered materials that provide support to providers as they have these difficult conversations. Continue reading
The Oregon State Drug Review: Update on Recent Guidance and Safety Alerts for Opioid Use in Non-cancer Pain
This 2019 update from the Oregon Drug Use Research & Management board provides recommendations for the use of opioids in treating non-cancer pain. The document summarizes guidelines on opioid prescribing produced by the Veterans Administration, the American Society of Interventional Pain Physicians, and the Oregon Health Authority. Continue reading
What Happens When You Flip the Script?
This 4 minute video from Minnesota’s Flip the Script campaign features interviews with a physician and patient about how the decision to change the patient’s opioid prescription improved the patient’s quality of life and the provider’s relationship to his patients and his practice. Continue reading
Minnesota Opioid Prescribing Guidelines – 2018 First Edition
The Minnesota Department of Human Services convened a group of stakeholders to address opioid prescribing in the state through the Opioid Prescribing Improvement Project. The Opioid Prescribing Workgroup produced these 2018 guidelines on opioid prescribing for use by providers Continue reading
Flip the Script: Discussion Guide for Non-Prescribers
A 4 page guide for non-prescribers about having difficult conversations with patients about pain management and opioids from Minnesota’s Flip the Script campaign. This guide provides information about the risks of long-term opioid therapy and provides information about understanding acute, post-acute and chronic pain. The guide provides talking points and specific language health care providers can use when talking to their patients and preparing patients to continue the discussion with their prescribing provider.